医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Theorem Clinical Research Expands Leadership and Prepares for Growth with Addition of Kathryn Bohannon and Angela Weston

2014年11月05日 PM10:00
このエントリーをはてなブックマークに追加


 

KING OF PRUSSIA, Pa.

Theorem Clinical Research, a leading contract research organization that optimizes trial conduct, has named Kathryn Bohannon as vice president of biopharmaceutical development and Angela Weston as vice president of business development in Europe and Asia.

Bohannon increases Theorem’s scientific and medical leadership in pediatrics and rare disease with almost 20 years of diverse pharmaceutical research and development experience, including Phase I-IV clinical research, laboratory research and development as well as U.S. and global project management and direct sales and marketing. She has developed and managed projects across multiple therapeutic areas and clinical settings, including the Best Pharmaceuticals for Children Act – Data Coordinating Center within the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Weston brings more than 20 years of experience to Theorem, spanning a broad range of commercial disciplines in the pharmaceutical, biotech and medical device industries. She has worked extensively in business development, previously serving as senior vice president for business development at a global clinical contract research organization. In this role, she organized and managed the pharmaceutical, medical device and clinical resource sales teams. Additionally, Weston is a clinical nurse specialist and paramedic.

“These professionals further enhance our capabilities and client services,” said John Potthoff, Theorem president and CEO. “We have the right experts in place to provide meaningful expertise in key aspects of clinical trials.”

Learn more about Theorem, its services and therapeutic areas of expertise at www.theoremclinical.com.

About Theorem Clinical Research

Theorem Clinical Research is a global provider of comprehensive clinical services with staff throughout the Americas, Europe and Asia and a client base comprised of the world’s leading biopharmaceutical and medical device companies. With industry-leading experts, unparalleled therapeutic expertise and innovative technology, Theorem is focused on analytic-based development, combination trials and personal data applications to simplify complex trials.

CONTACT

SCORR Marketing
Lea Studer, +1-308-237-5567
lea@scorrmarketing.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Brightree发布面向居家医疗器械的首个患者App
  • Brightreeが初のHME向け患者アプリを発表
  • Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
  • ポットネットワーク・ホールディングスがSEC報告会社登録に基づきPCAOB監査人による完全な監査・レビュー済みの財務報告書を公表
  • Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc